170 related articles for article (PubMed ID: 9864183)
21. In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator.
Hamilton JL; Imran Ul-Haq M; Abbina S; Kalathottukaren MT; Lai BF; Hatef A; Unniappan S; Kizhakkedathu JN
Biomaterials; 2016 Sep; 102():58-71. PubMed ID: 27322959
[TBL] [Abstract][Full Text] [Related]
22. Renal clearable nanochelators for iron overload therapy.
Kang H; Han M; Xue J; Baek Y; Chang J; Hu S; Nam H; Jo MJ; El Fakhri G; Hutchens MP; Choi HS; Kim J
Nat Commun; 2019 Nov; 10(1):5134. PubMed ID: 31723130
[TBL] [Abstract][Full Text] [Related]
23. Phenolic ethylenediamine derivatives: a study of orally effective iron chelators.
Hershko C; Grady RW; Link G
J Lab Clin Med; 1984 Mar; 103(3):337-46. PubMed ID: 6699459
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.
Bergeron RJ; Streiff RR; Creary EA; Daniels RD; King W; Luchetta G; Wiegand J; Moerker T; Peter HH
Blood; 1993 Apr; 81(8):2166-73. PubMed ID: 8471775
[TBL] [Abstract][Full Text] [Related]
25. Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network.
Faller B; Spanka C; Sergejew T; Tschinke V
J Med Chem; 2000 Apr; 43(8):1467-75. PubMed ID: 10780902
[TBL] [Abstract][Full Text] [Related]
26. Assessment of potential aluminum chelators in an octanol/aqueous system and in the aluminum-loaded rabbit.
Yokel RA; Kostenbauder HB
Toxicol Appl Pharmacol; 1987 Nov; 91(2):281-94. PubMed ID: 3672527
[TBL] [Abstract][Full Text] [Related]
27. Comparison of iron chelator efficacy in iron-overloaded beagle dogs and monkeys (Cebus apella).
Bergeron RJ; Wiegand J; Weimar WR; Lindstrom TC; Fannin TL; Ratliff-Thompson K
Comp Med; 2004 Dec; 54(6):664-72. PubMed ID: 15679265
[TBL] [Abstract][Full Text] [Related]
28. Multifunctional antioxidant activity of HBED iron chelator.
Samuni AM; Afeworki M; Stein W; Yordanov AT; DeGraff W; Krishna MC; Mitchell JB; Brechbiel MW
Free Radic Biol Med; 2001 Jan; 30(2):170-7. PubMed ID: 11163534
[TBL] [Abstract][Full Text] [Related]
29. Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis.
López-Rayo S; Hernández D; Lucena JJ
J Agric Food Chem; 2009 Sep; 57(18):8504-13. PubMed ID: 19689133
[TBL] [Abstract][Full Text] [Related]
30. Objectives and mechanism of iron chelation therapy.
Hershko C; Link G; Konijn AM; Cabantchik ZI
Ann N Y Acad Sci; 2005; 1054():124-35. PubMed ID: 16339658
[TBL] [Abstract][Full Text] [Related]
31. Mechanism-Based Pharmacokinetic Modeling of Absorption and Disposition of a Deferoxamine-Based Nanochelator in Rats.
Jones G; Zeng L; Kim J
Mol Pharm; 2023 Jan; 20(1):481-490. PubMed ID: 36378830
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of iron chelating and antioxidant potential of Epilobium hirsutum for the management of iron overload disease.
Sheikh NA; Desai TR; Tirgar PR
Biomed Pharmacother; 2017 May; 89():1353-1361. PubMed ID: 28320102
[TBL] [Abstract][Full Text] [Related]
33. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
[TBL] [Abstract][Full Text] [Related]
34. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).
Kontoghiorghes GJ; Pattichi K; Hadjigavriel M; Kolnagou A
Transfus Sci; 2000 Dec; 23(3):211-23. PubMed ID: 11099897
[TBL] [Abstract][Full Text] [Related]
35. Chelation therapy in beta-thalassemia: an optimistic update.
Giardina PJ; Grady RW
Semin Hematol; 2001 Oct; 38(4):360-6. PubMed ID: 11605171
[TBL] [Abstract][Full Text] [Related]
36. Deferoxamine pharmacokinetics.
Porter JB
Semin Hematol; 2001 Jan; 38(1 Suppl 1):63-8. PubMed ID: 11206963
[TBL] [Abstract][Full Text] [Related]
37. Desferri-Exochelin, a lipid-soluble, hexadentate iron chelator, effectively removes tissue iron.
Hodges YK; Weinberger HD; Stephens J; Horwitz MA; Horwitz LD
Transl Res; 2006 Aug; 148(2):63-71. PubMed ID: 16890146
[TBL] [Abstract][Full Text] [Related]
38. Radiation sensitization of mammalian cells by metal chelators.
Cook J
Radiat Res; 2001 Feb; 155(2):304-10. PubMed ID: 11175665
[TBL] [Abstract][Full Text] [Related]
39. Iron chelation therapy.
Hershko CM; Link GM; Konijn AM; Cabantchik ZI
Curr Hematol Rep; 2005 Mar; 4(2):110-6. PubMed ID: 15720959
[TBL] [Abstract][Full Text] [Related]
40. The origin of the differences in (R)- and (S)-desmethyldesferrithiocin. Iron-clearing properties.
Bergeron RJ; Wiegand J; Ratliff-Thompson K; Weimar WR
Ann N Y Acad Sci; 1998 Jun; 850():202-16. PubMed ID: 9668541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
